自食限制了依赖EGFR的瘤生长
Valeria R Fantin1, Robert T Abraham
1Oncology Research Unit, Pfizer Worldwide Research and Development, La Jolla, CA 92121, USA.
Cell
|September 17, 2013
概括
皮表皮生长因子受体 (EGFR) 信号驱动瘤生长通过抑制自. 这发生在贝克林1的酸化和无活化过程中,贝克林1是自过程中的关键蛋白质.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 自是一种细胞降解过程,对于维持细胞平衡至关重要.
- 自在癌症中的作用是复杂的,影响瘤抑制和进展.
- 细胞信号通路的失调经常在癌症中观察到.
研究的目的:
- 调查表皮生长因子受体 (EGFR) 信号在调节瘤生长过程中的自的作用.
- 阐明EGFR信号影响自的分子机制.
- 为了确定参与EGFR信号与自之间的交叉对话的关键蛋白质.
主要方法:
- 西方涂抹检测蛋白质酸化.
- 免疫沉以研究蛋白质相互作用.
- 基于细胞的测定用于监测自流量.
- 瘤异种移植模型以评估瘤生长 in vivo.
主要成果:
- 在瘤组织中发现EGFR信号传递升高.
- EGFR的激活导致贝克林1的酸化和失活.
- 贝克林1的酸化导致了自的抑制.
- 自的抑制促进了瘤细胞的增殖和瘤的生长.
结论:
- EGFR信号通过通过贝克林1无活化抑制自,促进瘤生长.
- 向EGFR-Beclin 1-自轴代表了癌症的潜在治疗策略.
更多相关视频
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
